Approximately 20–30% of glioblastoma tumors harbor a constitutively active rearrangement of EGFR, called EGFRvIII, but glioblastoma derived cell lines typically lose EGFR amplification and EGFRvIII expression [74], [75]. The gene discussed is EGFR; the disease is glioblastoma.